Table I.
Clinical Data of Study Population (n=52).
| Variable | Total n=52 | Group A (FTO Group) n=25 | Group B (PTO Group) n=27 | p Value (Between groups) |
|---|---|---|---|---|
| Age (Years) mean ± SD | 11.06±3.30 | 10.68±3.29 | 11.41± 3.34 | 0.433* |
| Gender | ||||
| Male | 17(65.4%) | 9(69.2%) | 8(61.5%) | 0.560** |
| Female | 9 (34.6%) | 4(30.8%) | 5(38.5%) | |
| Pre-treatment BCVA (logMAR) mean ± SD | 0.70±0.20 | 0.70±0.20 | 0.70±0.21 | 0.945* |
| Post-treatment BCVA (logMAR) mean ± SD | 0.29±0.18 | 0.23±0.15 | 0.35±0.20 | 0.023* |
| Improvement in Lines on Snellen’s Chart (no) mean ± SD | 1.92±1.35 | 2.20±1.38 | 1.67±1.30 | 0.158* |
Independent ‘t’ Test
Chi Square test.